Bio-Rad Laboratories Inc - Class A
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives.
Earnings per share grew at a -13.1% CAGR.
Current Price
$292.23
+1.41%GoodMoat Value
$938.27
221.1% undervaluedBio-Rad Laboratories Inc - Class A (BIO) Insider Trades
BIO Insider Trading Activity
Track insider trading transactions for Bio-Rad Laboratories Inc - Class A (BIO). Monitor recent buys, sells, and option exercises by officers, directors, and 10% beneficial owners. Insider trading activity can signal management confidence or concern about a stock's future prospects.
Current stock price: $292.23. Market cap: $7.88B. This page displays the most recent insider transactions for BIO, including the insider's name, title, transaction type (purchase, sale, or option exercise), number of shares, and total value. Filter transactions by type to focus on open-market purchases or sales.
Insider buying is often viewed as a bullish signal, as insiders are putting their own capital at risk. Conversely, large insider sales may warrant further investigation. Use GoodMoat's insider trading data alongside financial analysis, quality scores, and valuation tools for a comprehensive view of Bio-Rad Laboratories Inc - Class A's investment outlook.